Suven Life Sciences reveals breakthrough with Ropanicant in depression treatment

Suven Life Sciences Limited has made a significant advancement in the fight against depression, announcing positive results from a Phase-2a proof-of-concept study involving Ropanicant (SUVN-911). ... Read More